BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24365054)

  • 21. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
    J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
    Vallejo A; Loza E; Mateos ML
    J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
    [No Abstract]   [Full Text] [Related]  

  • 23. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
    Lal RB; Rudolph DL; Coligan JE; Brodine SK; Roberts CR
    Blood; 1992 Jul; 80(2):544-50. PubMed ID: 1627806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The trans-activating C-type retroviruses share a distinct epitope(s) that induces antibodies in certain infected hosts.
    Zandomeni RO; Carrera-Zandomeni M; Esteban E; Ferrer JF
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2113-9. PubMed ID: 1716653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first survey of human T-cell lymphotropic viruses (HTLV) in HIV/AIDS patients in Santa Catarina State, Brazil.
    Marcon CEM; Campos KR; Silva GBD; Schuelter-Trevisol F; Schlindwein AD; Trevisol DJ; Caterino-de-Araujo A
    Rev Inst Med Trop Sao Paulo; 2019; 61():e53. PubMed ID: 31618373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
    Enose-Akahata Y; Abrams A; Massoud R; Bialuk I; Johnson KR; Green PL; Maloney EM; Jacobson S
    Retrovirology; 2013 Feb; 10():19. PubMed ID: 23405908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An HTLV-I/II vaccine: from animal models to clinical trials?
    de Thé G; Kazanji M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S191-8. PubMed ID: 8797723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.
    Loughran TP; Hadlock KG; Yang Q; Perzova R; Zambello R; Semenzato G; Foung SK; Poiesz BJ
    Blood; 1997 Sep; 90(5):1977-81. PubMed ID: 9292532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative virology of HTLV-1 and HTLV-2.
    Martinez MP; Al-Saleem J; Green PL
    Retrovirology; 2019 Aug; 16(1):21. PubMed ID: 31391116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
    Lal RB; Buckner C; Khabbaz RF; Kaplan JE; Reyes G; Hadlock K; Lipka J; Foung SK; Chan L; Coligan JE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):40-9. PubMed ID: 7680300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.
    Sauter M; Schommer S; Kremmer E; Remberger K; Dölken G; Lemm I; Buck M; Best B; Neumann-Haefelin D; Mueller-Lantzsch N
    J Virol; 1995 Jan; 69(1):414-21. PubMed ID: 7983737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide.
    Lillehoj EP; Alexander SS; Dubrule CJ; Wiktor S; Adams R; Tai CC; Manns A; Blattner WA
    J Clin Microbiol; 1990 Dec; 28(12):2653-8. PubMed ID: 2279997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular detection and isolation of human T-cell lymphotropic virus type I (HTLV-I) from patients with HAM/TSP in São Paulo, Brazil.
    Segurado AA; Domingues RB; Muniz MR; Fink MC; Marchiori PE; Scaff M; Lal RB
    Clin Diagn Virol; 1998 Jan; 9(1):17-23. PubMed ID: 9562854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
    Farias de Carvalho SM; Pombo de Oliveira MS; Thuler LC; Rios M; Coelho RC; Rubim LC; Silva EM; Reis AM; Catovsky D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):238-42. PubMed ID: 9257659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
    Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
    Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.